The effect of the 2019 ESC/EAS dyslipidaemia guidelines on low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS EuroPath IV project-Reference-Cited by-同舟云学术

The effect of the 2019 ESC/EAS dyslipidaemia guidelines on low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS EuroPath IV project

Published:2023-02 Issue: Volume:148 Page:107141
ISSN:1537-1891
Container-title:Vascular Pharmacology
language:en
Short-container-title:Vascular Pharmacology

Author:

Laufs Ulrich,Catapano Alberico Luigi,De Caterina Raffaele,Schiele François,Sionis Alessandro,Zaman Azfar,Jukema J. Wouter

Funder

Sanofi US

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine,Physiology

Reference18 articles.

1. Mortality and morbidity trends after the first year in survivors of acute myocardial infarction: a systematic review;Johansson;BMC Cardiovasc. Disord.,2017

2. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

3. Implementation of clinical practices and pathways optimizing ACS patients lipid management: Focus on eight European initiatives;Alings;Atheroscler,2020

4. Role of lipid-lowering therapy in low-density lipoprotein cholesterol goal attainment: focus on patients with acute coronary syndrome;Wang;J. Cardiovasc. Pharmacol.,2020

5. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur. Heart J.,2020

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vergleich der LDL-Cholesterin-Serumkonzentrationen bei Patienten nach akutem Koronarsyndrom zwischen 2018 und 2022 in Deutschland und Europa;DMW - Deutsche Medizinische Wochenschrift;2024-08-07

2. Prognostic impact of high-intensity lipid-lowering therapy under-prescription after acute myocardial infarction in women;European Journal of Preventive Cardiology;2024-08-05

3. Differential Adherence to Free and Single-Pill Combination of Rosuvastatin/Ezetimibe: Findings from a Real-World Analysis in Italy;Advances in Therapy;2024-07-04

4. Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table;Journal of Clinical Lipidology;2024-07

5. Achievement of target LDL-cholesterol level in patients with acute coronary syndrome undergoing percutaneous coronary intervention: The JET-LDL registry;International Journal of Cardiology;2024-02